Cargando…

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer

PURPOSE: Stereotactic body radiation therapy (SBRT) can be easily used for patients with tumors in various organs and is a promising local therapy for eradicating tumors in cancer patients. There is a rising clinical need for increasing knowledge of oligometastases in the treatment of multiple pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishi, Noriko, Matsuo, Yukinori, Yoneyama, Masahiro, Ueki, Kazuhito, Mizowaki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133396/ https://www.ncbi.nlm.nih.gov/pubmed/35647407 http://dx.doi.org/10.1016/j.adro.2022.100911

Ejemplares similares

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
por: Ueki, Kazuhito, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach
por: Sherwani, Zohaib, et al.
Publicado: (2023)

Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020)

Lack of an association between marital status and survival in patients receiving stereotactic body radiotherapy for early-stage non-small-cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review
por: Almaghrabi, Mohammed Yahia, et al.
Publicado: (2012)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2021)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer
por: Mampuya, Wambaka Ange, et al.
Publicado: (2014)

Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
por: Chai, Guangjin, et al.
Publicado: (2020)

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes
por: Wang, Huan-Huan, et al.
Publicado: (2016)

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
por: Sogono, Paolo, et al.
Publicado: (2021)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
por: Lucido, J. John, et al.
Publicado: (2022)

Investigation of 4D dose in volumetric modulated arc therapy-based stereotactic body radiation therapy: does fractional dose or number of arcs matter?
por: Shintani, Takashi, et al.
Publicado: (2020)

Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century
por: Mheid, Sara, et al.
Publicado: (2023)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
por: Yamashita, Hideomi, et al.
Publicado: (2007)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
por: Duriseti, Sai, et al.
Publicado: (2021)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy
por: Chapman, Christopher H., et al.
Publicado: (2018)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease
por: Dohopolski, Michael J, et al.
Publicado: (2018)

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
por: Jiao, Yuxin, et al.
Publicado: (2020)

Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic Cancer
por: Kut, Carmen, et al.
Publicado: (2022)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
por: Naccarato, Stefania, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ia5ahr02d56cgavv86gltll03